Amedeo Smart

Free Medical Literature Service

 

Amedeo

Head and Neck Cancer
  Free Subscription

Articles published in
Br J Cancer
    October 2026
  1. GROTHEY B, Kramer M, Montalbano M, Lyu SI, et al
    Proteomic characterization of SMARCA-deficient esophageal adenocarcinoma reveals complement evasion and DNA repair-associated prognostic subgroups.
    Br J Cancer. 2026;135:1119-1130.
    >> Share

    September 2026
  2. TENGLER L, Jackson EK, Bieback K, Roth R, et al
    Small extracellular vesicles from the plasma of head and neck cancer patients induce dysfunctional T cell phenotypes.
    Br J Cancer. 2026 Sep 26. doi: 10.1038/s41416-026-03606.
    >> Share

  3. BHOL CS, Kar RK, Mishra SR, Mishra P, et al
    PAX9 activates autophagy through a transcription-dependent mechanism, promoting EGFR degradation to restrict cell survival in oral cancer.
    Br J Cancer. 2026 Sep 19. doi: 10.1038/s41416-026-03608.
    >> Share

  4. KONO T, Kasahara K, Ogawa R, Ozawa H, et al
    Radiomics as a spatial context for treatment decision-making in head and neck cancer.
    Br J Cancer. 2026 Sep 3. doi: 10.1038/s41416-026-03600.
    >> Share

  5. CHEN YW, Shiah SG, Yuan SS, Wang YY, et al
    A saliva-based surrogate associates with clinical outcome of oral potentially malignant disorders.
    Br J Cancer. 2026;135:818-829.
    >> Share

  6. YUAN J, Gong J, Peng Z, Liu TS, et al
    Efficacy and safety of infigratinib in patients with refractory advanced gastric or gastroesophageal junction adenocarcinoma harboring FGFR2 gene amplification: a single-arm, multicenter phase 2 trial.
    Br J Cancer. 2026;135:924-930.
    >> Share

    August 2026
  7. CHEN S, Wu Y, Rao G, Tong W, et al
    CD39(+)CD103(+)CD8(+) T cells enhance neoadjuvant chemoimmunotherapy efficacy in head and neck squamous cell carcinoma.
    Br J Cancer. 2026 Aug 20. doi: 10.1038/s41416-026-03588.
    >> Share

  8. SOUTHAM AD, Higginson JA, Lloyd GR, Smith MJ, et al
    Regional HNSCC metabolomics reveals widespread changes to one-carbon metabolism and S-adenosylmethionine metabolism across tumour core, tumour edge and adjacent non-tumour tissues.
    Br J Cancer. 2026;135:372-381.
    >> Share

  9. LIU C, Shen C, Hou Y, Du Y, et al
    Integrated multi-omics and single-cell analyses identify metabolic heterogeneity and therapeutic vulnerabilities in medullary thyroid cancer.
    Br J Cancer. 2026;135:546-558.
    >> Share

    July 2026
  10. VERMA TP, Singh S, Meloth S, Chaudhary N, et al
    Non-invasive biomarkers for early oral cancer detection through multiomics approach.
    Br J Cancer. 2026 Jul 21. doi: 10.1038/s41416-026-03540.
    >> Share

  11. GRUNWALD V, Alt J, Tometten M, Hanel M, et al
    OPTIM: a randomized phase II trial of nivolumab followed by nivolumab-ipilimumab or docetaxel at progression in recurrent/metastatic squamous cell carcinoma of the head and neck (OPTIM; AIO-KHT-0117).
    Br J Cancer. 2026 Jul 18. doi: 10.1038/s41416-026-03558.
    >> Share

  12. GOLDSTEIN MR, Mascitelli L, Mascitelli C
    Vegetarian diets and esophageal cancer risk.
    Br J Cancer. 2026 Jul 13. doi: 10.1038/s41416-026-03559.
    >> Share

  13. GORDON A, Tran A, Fong C, Cromarty S, et al
    Maintenance capecitabine after first-line platinum-based chemotherapy in advanced oesophagogastric adenocarcinoma: final analysis from the PLATFORM trial.
    Br J Cancer. 2026;135:240-247.
    >> Share

  14. FLANDERS L, Savy T, Ficial M, Al-Ghraibawi N, et al
    PD-L1 CPS in gastroesophageal cancer: differences in routine care versus Checkmate 649 and implications for biopsy-site choice and assay standardisation.
    Br J Cancer. 2026;135:232-239.
    >> Share

    June 2026
  15. LOPEZ JS, Harrington KJ, Im SA, Lee KW, et al
    Phase 1 study of ceralasertib, an ATR kinase inhibitor, in combination with durvalumab in patients with recurrent or metastatic NSCLC or HNSCC.
    Br J Cancer. 2026;134:1568-1579.
    >> Share

    May 2026
  16. ARDILA CM
    Ethnic and social inequities in oral cancer in Latin America-a call for regional vigilance.
    Br J Cancer. 2026 May 4. doi: 10.1038/s41416-026-03462.
    >> Share

  17. KAMP D, May AM, van Velzen MJM, Mook S, et al
    Association between effectiveness of treatment with curative intent and outcomes of first-line systemic therapy in metachronous metastatic gastroesophageal adenocarcinoma.
    Br J Cancer. 2026;134:1420-1428.
    >> Share

    April 2026
  18. CHEN K, Ni J, Li Y, Gu S, et al
    Identification of a distinct cluster of LY6E(+) macrophages in esophageal squamous cell carcinoma: functional phenotype, spatial interaction, and prognostic significance.
    Br J Cancer. 2026 Apr 29. doi: 10.1038/s41416-026-03456.
    >> Share

  19. ZHUO G, Li S, Yang G, Hu S, et al
    Alterations in NK cell subsets and the regulatory role of JAB1 in nasopharyngeal carcinoma with implications for tumor immunity and biomarker development.
    Br J Cancer. 2026 Apr 16. doi: 10.1038/s41416-026-03397.
    >> Share

    March 2026
  20. GUO WP, Yu X, Lu ZJ, Li YC, et al
    Incorporating early cfEBV DNA clearance into clinical risk stratification to tailor induction chemotherapy cycles for locoregionally advanced nasopharyngeal carcinoma.
    Br J Cancer. 2026 Mar 31. doi: 10.1038/s41416-026-03401.
    >> Share

  21. VAN HEUSDEN HC, de Bree R
    Sarcopenia in head and neck cancer: the complexity of skeletal muscle mass cut-off values.
    Br J Cancer. 2026 Mar 23. doi: 10.1038/s41416-026-03381.
    >> Share

  22. HUANG TC, Guo JC, Lin CC, Kuo HY, et al
    Neoadjuvant immunochemoradiotherapy with nivolumab, paclitaxel, and cisplatin followed by esophagectomy for locally advanced esophageal squamous cell carcinoma.
    Br J Cancer. 2026 Mar 20. doi: 10.1038/s41416-026-03349.
    >> Share

  23. ITOH G, Fukushi Y, Takagane K, Kanetaka K, et al
    Effects of mitotically active polyploid giant cancer cells on chemoresistance through interaction with cancer-associated fibroblasts.
    Br J Cancer. 2026;134:707-720.
    >> Share

  24. HOSE L, Tekin AC, Verwaaijen B, Kim R, et al
    Diagnostic accuracy of combinatorial mRNA biomarkers for non-invasive detection and therapy monitoring of oral and oropharyngeal SCC.
    Br J Cancer. 2026;134:961-974.
    >> Share

    February 2026
  25. EVANS M, Hurt C, Rhys R, Mahajan A, et al
    Correlation between imaging-detected and pathological extranodal extension in a randomised trial in Human Papillomavirus-positive oropharyngeal cancer.
    Br J Cancer. 2026;134:428-438.
    >> Share

  26. BI J, Liu K, Luo Y, Zhou Y, et al
    Crosstalk of NPY and TGFbeta orchestrates the signaling to facilitate perineural invasion of oral squamous cell carcinoma.
    Br J Cancer. 2026;134:377-390.
    >> Share

  27. MATEOS L, Jimenez-Fonseca P, Gallego J, Lecumberri A, et al
    Does perioperative FLOT increase cure rates in resectable esophageal adenocarcinoma? A mixture cure model analysis.
    Br J Cancer. 2026;134:414-427.
    >> Share


  28. Development and application of quality assurance methods for interventions in randomised controlled trials of surgical oncology: the ROMIO study (a comparison of minimally invasive and open oesophagectomy).
    Br J Cancer. 2026;134:404-413.
    >> Share

    January 2026
  29. BILSLAND AE, McCulloch E, Degerman S, Landfors M, et al
    Relative telomere length and senescence-associated inflammatory cytokines as blood-based prognostic markers in patients with advanced or resectable gastro-oesophageal adenocarcinoma.
    Br J Cancer. 2026;134:208-217.
    >> Share

  30. LIN LH, Chang KW, Cheng HW, Liu CJ, et al
    Profilin-2 promotes tumour aggressiveness in oral squamous cell carcinoma via HDAC1 modulation: implications for EMT and targeted therapy.
    Br J Cancer. 2026;134:331-341.
    >> Share

    December 2025
  31. LIU S, Xu Y, Guo X, Zhang W, et al
    Integrating lymphovascular invasion and ypTNM staging system for esophageal squamous cell carcinoma undergoing neoadjuvant chemoradiotherapy and surgery: a multi-institutional analysis.
    Br J Cancer. 2025 Dec 19. doi: 10.1038/s41416-025-03314.
    >> Share

  32. HE SQ, Huang Y, Zhao ZY, Wen SQ, et al
    Capecitabine combined with immunotherapy as maintenance therapy improves survival in recurrent/metastatic nasopharyngeal carcinoma: a retrospective cohort study.
    Br J Cancer. 2025 Dec 15. doi: 10.1038/s41416-025-03285.
    >> Share

    November 2025
  33. PAN KF, Chou HL, Wang WL, Chen BR, et al
    KSRP-mediated Wnt/beta-catenin activation promotes follicular thyroid cancer progression and stemness.
    Br J Cancer. 2025;133:1111-1121.
    >> Share

    October 2025
  34. DU Y, Feng R, Chang ET, Yin L, et al
    Population-based nasopharyngeal carcinoma survival in southern China.
    Br J Cancer. 2025 Oct 29. doi: 10.1038/s41416-025-03232.
    >> Share

  35. KAUR R, Chauhan A, Saini KK, Datta A, et al
    Cornulin, a potential prognostic biomarker in head and neck squamous cell carcinoma, acts as an anti-tumour agent by inhibiting cell cycle through upregulation of p18.
    Br J Cancer. 2025 Oct 27. doi: 10.1038/s41416-025-03222.
    >> Share

  36. WU WZ, Huang HC, Zhu GH, Liao LD, et al
    Serum multiomics prediction of prognosis and adverse reactions to concurrent chemoradiotherapy in patients with esophageal cancer.
    Br J Cancer. 2025 Oct 8. doi: 10.1038/s41416-025-03229.
    >> Share

  37. CUI K, Hu S, Zha Y, Ding K, et al
    Correction: CD49a(+) NK cells promote esophageal cancer development by inducing MDSCs infiltration via GM-CSF.
    Br J Cancer. 2025 Oct 6. doi: 10.1038/s41416-025-03220.
    >> Share

  38. YADOLLAHI P, McCord KA, Li Y, Dayoub H, et al
    Bypassing cisplatin resistance in Nrf2 hyperactivated head and neck cancer through effective PI3Kinase targeting.
    Br J Cancer. 2025 Oct 6. doi: 10.1038/s41416-025-03189.
    >> Share

  39. PATIL N, Lal Z, Sridhar T, Pareek M, et al
    A call for action: closing the gap on ethnic disparities in oral cavity cancer care.
    Br J Cancer. 2025;133:917-918.
    >> Share

    September 2025
  40. WU KP, Luo XQ, Li QQ, Yang HC, et al
    Efficacy and safety of induction immunotherapy plus chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: a meta-analysis.
    Br J Cancer. 2025 Sep 5. doi: 10.1038/s41416-025-03169.
    >> Share

  41. LI Y, Yuan X, Yin XF, Zheng D, et al
    Proteomics analysis and immune profiling reveal regulators of PD-L1 in oesophageal squamous cell carcinoma.
    Br J Cancer. 2025;133:448-463.
    >> Share

  42. WALKER RC, Breininger SP, Sharpe BP, Harrington J, et al
    Cancer-associated fibroblasts are associated with neo-adjuvant treatment response in oesophageal adenocarcinoma.
    Br J Cancer. 2025;133:633-647.
    >> Share

  43. SPENDER LC, Watt DM, Baxter MA, Shuttleworth MK, et al
    AKT/mTOR as a targetable hub to overcome multimodal resistance to EGFR inhibitors in oesophageal squamous cell carcinoma.
    Br J Cancer. 2025;133:709-722.
    >> Share

    August 2025
  44. LAN K, Li S, Jia G, Li S, et al
    Correction: Biomarkers of response to camrelizumab combined with apatinib: an analysis from a phase II trial in recurrent/metastatic nasopharyngeal carcinoma.
    Br J Cancer. 2025 Aug 27. doi: 10.1038/s41416-025-03077.
    >> Share

  45. KO JM, Guo C, Leung AK, Chan SC, et al
    Oncogenic NFE2L2 mutations in plasma ctDNA and tumors are predictors and prognosticators of chemoradiation therapy in resectable esophageal squamous cell carcinoma.
    Br J Cancer. 2025 Aug 8. doi: 10.1038/s41416-025-03113.
    >> Share

    July 2025
  46. FAN C, Liu F, He C, Liu J, et al
    Radiotherapy combined with anlotinib in locoregional recurrent esophageal squamous cell carcinoma after radical surgery: a prospective, Phase II clinical trial.
    Br J Cancer. 2025 Jul 16. doi: 10.1038/s41416-025-03101.
    >> Share

  47. ADACHI K, Yamashita K, Kamakura Y, Momose K, et al
    High expression of the cachexia-related protein Fn14 in esophageal squamous cell carcinoma correlates with poor chemotherapy response and anti-Fn14 therapy decreases chemotherapeutic resistance.
    Br J Cancer. 2025 Jul 15. doi: 10.1038/s41416-025-03087.
    >> Share

    June 2025
  48. VAN HEUSDEN HC, van Beers MA, Schaeffers AWMA, Swartz E, et al
    The predictive and prognostic role of radiologically defined sarcopenia in head and neck cancer: a systematic review and multi-level meta-analysis.
    Br J Cancer. 2025 Jun 2. doi: 10.1038/s41416-025-03049.
    >> Share

  49. TRAN TV, O'Brien KM, Troisi R, Sandler DP, et al
    In-utero and newborn factors and thyroid cancer incidence in adult women in the Sister Study cohort.
    Br J Cancer. 2025;132:1056-1063.
    >> Share

  50. DE OLIVEIRA THA, Anderson LA, Craig SG, Coleman HG, et al
    Infectious agents and progression from Barrett's oesophagus to oesophageal adenocarcinoma: a nested case-control study.
    Br J Cancer. 2025;132:1050-1055.
    >> Share

    May 2025
  51. CUI K, Hu S, Zha Y, Ding K, et al
    CD49a(+) NK cells promote esophageal cancer development by inducing MDCSs infiltration via GM-CSF.
    Br J Cancer. 2025 May 28. doi: 10.1038/s41416-025-03065.
    >> Share

  52. PAPANIKOLAOU C, Economopoulou P, Spathis A, Kotsantis I, et al
    Association of DNA damage response signals and oxidative stress status with nivolumab efficacy in patients with Head and Neck Squamous Cell Carcinoma.
    Br J Cancer. 2025 May 23. doi: 10.1038/s41416-025-03032.
    >> Share

  53. FEI-ZHANG DJ, Cuenca CM, Haskins AD, Stein AP, et al
    Assessments of social vulnerability on laryngeal cancer treatment & prognosis in the US.
    Br J Cancer. 2025 May 15. doi: 10.1038/s41416-025-03056.
    >> Share

  54. LAN K, Li S, Jia G, Li S, et al
    Biomarkers of response to camrelizumab combined with apatinib: an analysis from a phase II trial in recurrent/metastatic nasopharyngeal carcinoma.
    Br J Cancer. 2025 May 12. doi: 10.1038/s41416-025-03044.
    >> Share

  55. CHENG H, Chen J, Li Y, Li Y, et al
    Determining the optimal duration of oral adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma.
    Br J Cancer. 2025 May 6. doi: 10.1038/s41416-025-03033.
    >> Share

  56. HUBER D, Kors TA, Schutt L, Hofmann L, et al
    The role of plasma-derived small extracellular vesicles in pre-metastatic niche formation through modulation of macrophages in head and neck squamous cell carcinoma.
    Br J Cancer. 2025 May 5. doi: 10.1038/s41416-025-03001.
    >> Share

    April 2025
  57. INOUE-CHOI M, Ramirez Y, O'Connell C, Berrington de Gonzalez A, et al
    Hot beverage intake and oesophageal cancer in the UK Biobank: prospective cohort study.
    Br J Cancer. 2025;132:652-659.
    >> Share

  58. HUANG G, Chen S, Han B, Zhang G, et al
    Apolipoprotein D is crucial for promoting perineural invasion in salivary adenoid cystic carcinoma.
    Br J Cancer. 2025;132:599-610.
    >> Share

    March 2025
  59. LU X, Lin W, Zheng J, Huang W, et al
    Sodium nitrite orchestrates macrophage mimicry of tongue squamous carcinoma cells to drive lymphatic metastasis.
    Br J Cancer. 2025;132:340-353.
    >> Share

    February 2025
  60. SHEPHARD AJ, Mahmood H, Raza SEA, Khurram SA, et al
    A novel AI-based score for assessing the prognostic value of intra-epithelial lymphocytes in oral epithelial dysplasia.
    Br J Cancer. 2025;132:168-179.
    >> Share

  61. STOGBAUER F, Wirth M, Lauterbach M, Wollenberg B, et al
    Tumor budding and lymphovascular invasion as prognostic factors in p16-positive oropharyngeal squamous cell carcinomas.
    Br J Cancer. 2025;132:212-221.
    >> Share

  62. BARGHOUT SH, Meti N, Chotai S, Kim CJH, et al
    Adaptive Universal Principles for Real-world Observational Studies (AUPROS): an approach to designing real-world observational studies for clinical, epidemiologic, and precision oncology research.
    Br J Cancer. 2025;132:139-153.
    >> Share

    December 2024
  63. LIN J, Orestes MI, Shriver CD, Zhu K, et al
    Post-diagnosis statin use and survival among head and neck cancer patients: a cohort study in a universal health care system.
    Br J Cancer. 2024 Dec 7. doi: 10.1038/s41416-024-02925.
    >> Share

    November 2024
  64. EKSTEDT S, Piersiala K, Kolev A, Farrajota Neves da Silva P, et al
    Phenotypical differences of neutrophils patrolling tumour-draining lymph nodes in head and neck cancer.
    Br J Cancer. 2024 Nov 14. doi: 10.1038/s41416-024-02891.
    >> Share

    October 2024
  65. HOLZMANN KLK, Wolf JL, Stangl S, Lennartz P, et al
    Improved ex vivo fluorescence imaging of human head and neck cancer using the peptide tracer TPP-IRDye800 targeting membrane-bound Hsp70 on tumor cells.
    Br J Cancer. 2024 Oct 15. doi: 10.1038/s41416-024-02872.
    >> Share

  66. ZHOU J, Zhao G, Wang S, Li N, et al
    Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review of the last decade.
    Br J Cancer. 2024;131:1021-1031.
    >> Share

  67. CHEN YY, Wang PP, Hu Y, Yuan Y, et al
    Clinical efficacy and immune response of neoadjuvant camrelizumab plus chemotherapy in resectable locally advanced oesophageal squamous cell carcinoma: a phase 2 trial.
    Br J Cancer. 2024;131:1126-1136.
    >> Share

    September 2024
  68. WANG R, Liu S, Chen B, Li Q, et al
    Prognostic significance of PET/CT and its association with immuno-genomic profiling in oesophageal squamous cell carcinoma treated with immunotherapy plus chemoradiotherapy: results from a phase II study.
    Br J Cancer. 2024;131:709-717.
    >> Share

    July 2024
  69. HARA Y, Baba Y, Oda E, Harada K, et al
    Presence of Fusobacterium nucleatum in relation to patient survival and an acidic environment in oesophagogastric junction and gastric cancers.
    Br J Cancer. 2024 Jul 12. doi: 10.1038/s41416-024-02753.
    >> Share

  70. LI T, Sun G, Ye H, Song C, et al
    ESCCPred: a machine learning model for diagnostic prediction of early esophageal squamous cell carcinoma using autoantibody profiles.
    Br J Cancer. 2024 Jul 2. doi: 10.1038/s41416-024-02781.
    >> Share

    May 2024
  71. ZHANG D, Jiang D, Jiang L, Ma J, et al
    HLA-A(+) tertiary lymphoid structures with reactivated tumor infiltrating lymphocytes are associated with a positive immunotherapy response in esophageal squamous cell carcinoma.
    Br J Cancer. 2024 May 18. doi: 10.1038/s41416-024-02712.
    >> Share

  72. OLIVA M, Heirali A, Watson G, Rooney AM, et al
    Prospective manipulation of the gut microbiome with microbial ecosystem therapeutic 4 (MET4) in HPV-related locoregionally-advanced oropharyngeal cancer squamous cell carcinoma (LA-OPSCC) undergoing primary chemoradiation: ROMA2 study.
    Br J Cancer. 2024 May 7. doi: 10.1038/s41416-024-02701.
    >> Share

  73. WANG C, Li Y, Wang L, Han Y, et al
    SPP1 represents a therapeutic target that promotes the progression of oesophageal squamous cell carcinoma by driving M2 macrophage infiltration.
    Br J Cancer. 2024;130:1770-1782.
    >> Share

  74. WANG Z, Tang S, Cai L, Wang Q, et al
    DRP1 inhibition-mediated mitochondrial elongation abolishes cancer stemness, enhances glutaminolysis, and drives ferroptosis in oral squamous cell carcinoma.
    Br J Cancer. 2024;130:1744-1757.
    >> Share

  75. SIJBEN J, Huibertse LJ, Rainey L, Broeders MJM, et al
    Oesophageal cancer awareness and anticipated time to help-seeking: results from a population-based survey.
    Br J Cancer. 2024;130:1795-1802.
    >> Share

    April 2024
  76. MAKOWSKA A, Kontny U, Weiskirchen R
    HeLa cells cross-contaminated nasopharyngeal carcinoma cell lines: Still a common problem.
    Br J Cancer. 2024 Apr 25. doi: 10.1038/s41416-024-02675.
    >> Share

  77. TABATABAEIAN H, Bai Y, Huang R, Chaurasia A, et al
    Navigating therapeutic strategies: HPV classification in head and neck cancer.
    Br J Cancer. 2024 Apr 20. doi: 10.1038/s41416-024-02655.
    >> Share

    March 2024
  78. HIRAI R, Kinugasa H, Yamamoto S, Ako S, et al
    Methylation analysis of DCC gene in saliva samples is an efficient method for non-invasive detection of superficial hypopharyngeal cancer.
    Br J Cancer. 2024 Mar 27. doi: 10.1038/s41416-024-02654.
    >> Share

  79. XU J, Chen D, Wu W, Ji X, et al
    A metabolic map and artificial intelligence-aided identification of nasopharyngeal carcinoma via a single-cell Raman platform.
    Br J Cancer. 2024 Mar 7. doi: 10.1038/s41416-024-02637.
    >> Share

  80. SHANG Q, Jiang Y, Wan Z, Peng J, et al
    The clinical implication and translational research of OSCC differentiation.
    Br J Cancer. 2024;130:660-670.
    >> Share

  81. CHENG Z, Johar A, Nilsson M, Schandl A, et al
    Cancer-related fatigue trajectories up to 5 years after curative treatment for oesophageal cancer.
    Br J Cancer. 2024;130:628-637.
    >> Share

    February 2024
  82. CECCHINI M, Cleary JM, Shyr Y, Chao J, et al
    NCI10066: a Phase 1/2 study of olaparib in combination with ramucirumab in previously treated metastatic gastric and gastroesophageal junction adenocarcinoma.
    Br J Cancer. 2024;130:476-482.
    >> Share

  83. JAVED SR, Lord S, El Badri S, Harman R, et al
    CHARIOT: a phase I study of berzosertib with chemoradiotherapy in oesophageal and other solid cancers using time to event continual reassessment method.
    Br J Cancer. 2024;130:467-475.
    >> Share

    January 2024
  84. LIN W, Chen X, Huang Z, Ding Q, et al
    Identification of novel molecular subtypes to improve the classification framework of nasopharyngeal carcinoma.
    Br J Cancer. 2024 Jan 27. doi: 10.1038/s41416-024-02579.
    >> Share

  85. LI G, Wang H, Zhong J, Bai Y, et al
    Circulating small extracellular vesicle-based miRNA classifier for follicular thyroid carcinoma: a diagnostic study.
    Br J Cancer. 2024 Jan 18. doi: 10.1038/s41416-024-02575.
    >> Share

  86. CHEN Y, Feng Y, Lin Y, Zhou X, et al
    GSTM3 enhances radiosensitivity of nasopharyngeal carcinoma by promoting radiation-induced ferroptosis through USP14/FASN axis and GPX4.
    Br J Cancer. 2024 Jan 16. doi: 10.1038/s41416-024-02574.
    >> Share

  87. STOGBAUER F, Beck S, Ourailidis I, Hess J, et al
    Correction: Tumour budding-based grading as independent prognostic biomarker in HPV-positive and HPV-negative head and neck cancer.
    Br J Cancer. 2024 Jan 8. doi: 10.1038/s41416-023-02521.
    >> Share

  88. HUANG Q, Liu Z, Yu Y, Rong Z, et al
    Prediction of response to neoadjuvant chemo-immunotherapy in patients with esophageal squamous cell carcinoma by a rapid breath test.
    Br J Cancer. 2024 Jan 4. doi: 10.1038/s41416-023-02547.
    >> Share

  89. CLEMENTS HA, Underwood TJ, Petty RD
    Total neoadjuvant therapy in oesophageal and gastro-oesophageal junctional adenocarcinoma.
    Br J Cancer. 2024;130:9-18.
    >> Share

    December 2023
  90. ALMANGUSH A, Makitie AA, Leivo I
    Tumour budding in head and neck cancer: what have we learnt and the next steps towards clinical implementation.
    Br J Cancer. 2023 Dec 14. doi: 10.1038/s41416-023-02531.
    >> Share

  91. SARODE G, Sarode SC
    Comment on "Development and validation of a multivariable model for prediction of malignant transformation and recurrence of oral epithelial dysplasia".
    Br J Cancer. 2023;129:1875-1876.
    >> Share

    November 2023
  92. MAHMOOD H, Shephard A, Hankinson P, Bradburn M, et al
    Development and validation of a multivariable model for prediction of malignant transformation and recurrence of oral epithelial dysplasia.
    Br J Cancer. 2023;129:1599-1607.
    >> Share

  93. MENG X, Zheng A, Wang J, Wu X, et al
    Nimotuzumab plus concurrent chemo-radiotherapy in unresectable locally advanced oesophageal squamous cell carcinoma (ESCC): interim analysis from a Phase 3 clinical trial.
    Br J Cancer. 2023;129:1787-1792.
    >> Share

  94. TOWLE R, Dickman CTD, MacLellan SA, Chen J, et al
    Identification of a serum-based microRNA signature that detects recurrent oral squamous cell carcinoma before it is clinically evident.
    Br J Cancer. 2023;129:1810-1817.
    >> Share

    October 2023
  95. LIU JY, Yu ZL, Fu QY, Zhang LZ, et al
    Immunosuppressive effect of small extracellular vesicle PD-L1 is restricted by co-expression of CD80.
    Br J Cancer. 2023;129:925-934.
    >> Share

    September 2023
  96. PAYNE K, Brooks J, Batis N, Khan N, et al
    Feasibility of mass cytometry proteomic characterisation of circulating tumour cells in head and neck squamous cell carcinoma for deep phenotyping.
    Br J Cancer. 2023 Sep 21. doi: 10.1038/s41416-023-02428.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016